H-Index & Metrics Best Publications

H-Index & Metrics

Discipline name H-index Citations Publications World Ranking National Ranking
Biology and Biochemistry D-index 64 Citations 19,725 135 World Ranking 4283 National Ranking 72

Overview

What is she best known for?

The fields of study she is best known for:

  • Gene
  • Immune system
  • Cytokine

Her scientific interests lie mostly in Receptor, Cell biology, Molecular biology, Natural killer cell and NKG2D. Her Receptor research integrates issues from Natural Cytotoxicity Triggering Receptor 1, Antibody and Lysine. The various areas that Claudia Cantoni examines in her Cell biology study include Cell culture, Cytokine, Lymphokine-activated killer cell and Cytotoxicity.

While the research belongs to areas of Lymphokine-activated killer cell, Claudia Cantoni spends her time largely on the problem of NK-92, intersecting her research to questions surrounding Cancer research. Her Molecular biology research includes themes of Signal transduction, CD94/NKG2 and Immunoglobulin superfamily. She combines subjects such as Human leukocyte antigen, Immunology and Major histocompatibility complex with her study of Natural killer cell.

Her most cited work include:

  • Activating Receptors and Coreceptors Involved in Human Natural Killer Cell-Mediated Cytolysis (1532 citations)
  • Identification of PVR (CD155) and Nectin-2 (CD112) as Cell Surface Ligands for the Human DNAM-1 (CD226) Activating Molecule (661 citations)
  • Identification of PVR (CD155) and Nectin-2 (CD112) as Cell Surface Ligands for the Human DNAM-1 (CD226) Activating Molecule (661 citations)

What are the main themes of her work throughout her whole career to date?

The scientist’s investigation covers issues in Receptor, Cell biology, Immunology, Interleukin 21 and Molecular biology. Her work carried out in the field of Receptor brings together such families of science as Cell, Natural killer cell, Cytolysis, Cytotoxicity and Human leukocyte antigen. Her study looks at the relationship between Cytotoxicity and fields such as Peptide sequence, as well as how they intersect with chemical problems.

Her studies deal with areas such as NKG2D, Cell surface receptor, Immune system and Cell growth as well as Cell biology. Her study looks at the intersection of Interleukin 21 and topics like Interleukin 12 with Interleukin 2. Her work deals with themes such as Cell culture, CD3, CD94/NKG2 and Immunoglobulin superfamily, which intersect with Molecular biology.

She most often published in these fields:

  • Receptor (76.77%)
  • Cell biology (74.84%)
  • Immunology (51.61%)

What were the highlights of her more recent work (between 2013-2021)?

  • Cell (33.55%)
  • Cancer research (26.45%)
  • Immunology (51.61%)

In recent papers she was focusing on the following fields of study:

Claudia Cantoni spends much of her time researching Cell, Cancer research, Immunology, Immune system and Receptor. She has included themes like Epithelial–mesenchymal transition, Downregulation and upregulation, Cell culture, Tumor progression and Leukemia in her Cancer research study. Claudia Cantoni focuses mostly in the field of Immunology, narrowing it down to matters related to Interleukin 12 and, in some cases, Cell biology.

The concepts of her Cell biology study are interwoven with issues in Cancer cell, Natural killer cell and Cell type. Her Immune system research focuses on Cytotoxic T cell and how it relates to Chemokine and Inflammation. Her Receptor study combines topics from a wide range of disciplines, such as Extracellular, Virus, Human leukocyte antigen, Cytotoxicity and Extracellular matrix.

Between 2013 and 2021, her most popular works were:

  • Effect of tumor cells and tumor microenvironment on NK-cell function (196 citations)
  • Effect of tumor cells and tumor microenvironment on NK-cell function (196 citations)
  • NCR(+)ILC3 concentrate in human lung cancer and associate with intratumoral lymphoid structures. (125 citations)

In her most recent research, the most cited papers focused on:

  • Gene
  • Immune system
  • Cytokine

Her main research concerns Receptor, Cancer research, Cell, Immunology and Cell culture. She has researched Receptor in several fields, including Extracellular matrix, Cell biology and Cytotoxicity. Her Cell research focuses on subjects like Leukemia, which are linked to Monoclonal antibody, Metastasis, Human leukocyte antigen and Hematopoietic stem cell transplantation.

Her research investigates the connection between Immunology and topics such as Interleukin 12 that intersect with problems in Downregulation and upregulation and Phenotype. Her study in Cell culture is interdisciplinary in nature, drawing from both Cancer, Chimeric antigen receptor and Electroporation, Gene. Her NK Cell Lectin-Like Receptor Subfamily K study in the realm of Interleukin 21 connects with subjects such as Myeloid-derived Suppressor Cell.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Activating Receptors and Coreceptors Involved in Human Natural Killer Cell-Mediated Cytolysis

Alessandro Moretta;Cristina Bottino;Massimo Vitale;Daniela Pende.
Annual Review of Immunology (2001)

1937 Citations

Identification of PVR (CD155) and Nectin-2 (CD112) as Cell Surface Ligands for the Human DNAM-1 (CD226) Activating Molecule

Cristina Bottino;Roberta Castriconi;Daniela Pende;Paola Rivera.
Journal of Experimental Medicine (2003)

808 Citations

Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra- and intracellular domains

Nicolai Wagtmann;Roberto Biassoni;Claudia Cantoni;Simonetta Verdiani.
Immunity (1995)

680 Citations

Transforming growth factor β1 inhibits expression of NKp30 and NKG2D receptors: Consequences for the NK-mediated killing of dendritic cells

Roberta Castriconi;Claudia Cantoni;Mariella Della Chiesa;Massimo Vitale.
Proceedings of the National Academy of Sciences of the United States of America (2003)

588 Citations

The natural killer cell receptor specific for HLA-A allotypes: a novel member of the p58/p70 family of inhibitory receptors that is characterized by three immunoglobulin-like domains and is expressed as a 140-kD disulphide-linked dimer.

D Pende;R Biassoni;C Cantoni;S Verdiani.
Journal of Experimental Medicine (1996)

548 Citations

NKp44, a triggering receptor involved in tumor cell lysis by activated human natural killer cells, is a novel member of the immunoglobulin superfamily.

Claudia Cantoni;Cristina Bottino;Massimo Vitale;Anna Pessino.
Journal of Experimental Medicine (1999)

489 Citations

The human leukocyte antigen (HLA)-C-specific "activatory" or "inhibitory" natural killer cell receptors display highly homologous extracellular domains but differ in their transmembrane and intracytoplasmic portions.

Roberto Biassoni;Claudia Cantoni;Michela Falco;Simonetta Verdiani.
Journal of Experimental Medicine (1996)

480 Citations

Role of NKG2D in tumor cell lysis mediated by human NK cells: cooperation with natural cytotoxicity receptors and capability of recognizing tumors of nonepithelial origin.

Daniela Pende;Claudia Cantoni;Claudia Cantoni;Paola Rivera;Massimo Vitale.
European Journal of Immunology (2001)

426 Citations

Inhibitory receptors sensing HLA-G1 molecules in pregnancy: Decidua-associated natural killer cells express LIR-1 and CD94/NKG2A and acquire p49, an HLA-G1-specific receptor

Marco Ponte;Claudia Cantoni;Roberto Biassoni;Andrea Tradori-Cappai.
Proceedings of the National Academy of Sciences of the United States of America (1999)

389 Citations

Revisiting human natural killer cell subset function revealed cytolytic CD56dimCD16+ NK cells as rapid producers of abundant IFN-γ on activation

Andrea De Maria;Federica Bozzano;Claudia Cantoni;Lorenzo Moretta.
Proceedings of the National Academy of Sciences of the United States of America (2011)

381 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Claudia Cantoni

Lorenzo Moretta

Lorenzo Moretta

Bambino Gesù Children's Hospital

Publications: 304

Alessandro Moretta

Alessandro Moretta

University of Genoa

Publications: 214

Maria Cristina Mingari

Maria Cristina Mingari

University of Genoa

Publications: 121

Eric Vivier

Eric Vivier

Aix-Marseille University

Publications: 111

Cristina Bottino

Cristina Bottino

University of Genoa

Publications: 96

Ofer Mandelboim

Ofer Mandelboim

Hebrew University of Jerusalem

Publications: 91

Lewis L. Lanier

Lewis L. Lanier

University of California, San Francisco

Publications: 90

Mark J. Smyth

Mark J. Smyth

QIMR Berghofer Medical Research Institute

Publications: 77

Armand Bensussan

Armand Bensussan

Inserm : Institut national de la santé et de la recherche médicale

Publications: 75

Daniela Pende

Daniela Pende

University of Genoa

Publications: 72

Marco Colonna

Marco Colonna

Washington University in St. Louis

Publications: 71

Peter Parham

Peter Parham

Stanford University

Publications: 65

Simona Sivori

Simona Sivori

University of Genoa

Publications: 59

David H. Raulet

David H. Raulet

University of California, Berkeley

Publications: 58

Miguel López-Botet

Miguel López-Botet

Pompeu Fabra University

Publications: 55

Roberto Biassoni

Roberto Biassoni

Istituto Giannina Gaslini

Publications: 54

Something went wrong. Please try again later.